Fatal2009 pandemic influenza a (H1N1) in a bone marrow transplant recipient

3Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

Abstract

Conditions characterized by immunosuppression have been recently reported as risk factors for severe novel swine-origin influenza A (H1N1) virus (S-OIV) infection during the current 2009 pandemic. We report clinical and virological findings, antiviral therapy, and postmortem study of S-OIV in an adult bone marrow transplant recipient. The viral genome was amplified by real time reverse transcriptase polymerase chain reaction (RT-PCR) from a nasopharyngeal swab specimen. The patient developed acute respiratory distress syndrome, septic shock, and eventually succumbed with a severe pulmonary haemorrhage. To the best of our knowledge, the entire clinical/therapy management and pathological examination in a transplant recipient infected with the S-OIV has not been previously documented. The fatal ending in this bone marrow transplant recipient supports recommendations that call for education measures, S-OIV vaccination, early diagnosis and aggressive treatment in the transplant population. © 2011 Abdo et al.

Cite

CITATION STYLE

APA

Abdo, A., Alfonso, C., Diaz, G., Wilford, M., Rocha, M., & Verdecia, N. (2011). Fatal2009 pandemic influenza a (H1N1) in a bone marrow transplant recipient. Journal of Infection in Developing Countries, 5(2), 132–137. https://doi.org/10.3855/jidc.1066

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free